Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Simone

Showing results (351-360 of 372) with videos related to

Pageof 38
Sort By:
Clinical Genitourinary Cancer|September 4, 2023
Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial CarcinomaMatteo Ferro, Sever Chiujdea, Mihai Dorin Vartolomei, et al.
Urologic Oncology|April 12, 2026
The impact of age in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-GuérinPietro Scilipoti, Paolo Zaurito, Mattia Longoni, et al.
World Journal of Urology|February 9, 2019
Robotic versus laparoscopic radical nephrectomy: a large multi-institutional analysis (ROSULA Collaborative Group)Uzoma A Anele, Michele Marchioni, Bo Yang, et al.
Urologic Oncology|April 4, 2026
Risk stratification of Ta high-grade non-muscle-invasive bladder cancer: Insights from a multicenter cohort studyPaolo Zaurito, Pietro Scilipoti, Mattia Longoni, et al.
Minerva Urology and Nephrology|April 23, 2026
Real-world multicenter adherence to international guidelines in the management of upper tract urothelial carcinoma: insights from the ROBUUST 2.0 RegistryMariaconsiglia Ferriero, Gabriele Tuderti, Flavia Proietti, et al.
World Journal of Urology|April 18, 2025
Combined neoadjuvant and adjuvant therapy versus adjuvant therapy in high-risk upper tract urothelial carcinoma: a propensity matched multicenter analysis (ROBUUST 2.0 International Collaborative Group)Ahmed Eraky, Reuben Ben-David, Gabriele Bignante, et al.
Urologic Oncology|March 3, 2026
Perioperative and oncologic outcomes of extirpative surgery for upper tract urothelial cancer in octogenariansTaibo Li, Stephan Brönimann, Ahmed Eraky, et al.
World Journal of Urology|January 11, 2026
Real-world outcomes of bladder-sparing strategies for BCG-unresponsive non-muscle-invasive bladder cancer: a multicenter studyPietro Scilipoti, Paolo Zaurito, Mattia Longoni, et al.
Urology Practice|June 22, 2026
Metachronous contralateral recurrence in upper tract urothelial carcinoma: a multi-institutional competing-risks analysis from the ROBUUST 3.0 registryFrancesco Ditonno, Alessandro Veccia, Giacomo Musso, et al.
World Journal of Urology|September 2, 2025
Radical nephroureterectomy vs kidney sparing surgery for upper tract urothelial carcinoma in solitary kidney patients: a multi-institutional analysis of the ROBUUST 2.0 registryFrancesco Ditonno, Alessandro Veccia, Gabriele Bignante, et al.
Pageof 38

Showing results (351-360 of 372) with videos related to

Sort By:
Pageof 38
Clinical Genitourinary Cancer|September 4, 2023
Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract Urothelial CarcinomaMatteo Ferro, Sever Chiujdea, Mihai Dorin Vartolomei, et al.
Urologic Oncology|April 12, 2026
The impact of age in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-GuérinPietro Scilipoti, Paolo Zaurito, Mattia Longoni, et al.
World Journal of Urology|February 9, 2019
Robotic versus laparoscopic radical nephrectomy: a large multi-institutional analysis (ROSULA Collaborative Group)Uzoma A Anele, Michele Marchioni, Bo Yang, et al.
Urologic Oncology|April 4, 2026
Risk stratification of Ta high-grade non-muscle-invasive bladder cancer: Insights from a multicenter cohort studyPaolo Zaurito, Pietro Scilipoti, Mattia Longoni, et al.
Minerva Urology and Nephrology|April 23, 2026
Real-world multicenter adherence to international guidelines in the management of upper tract urothelial carcinoma: insights from the ROBUUST 2.0 RegistryMariaconsiglia Ferriero, Gabriele Tuderti, Flavia Proietti, et al.
World Journal of Urology|April 18, 2025
Combined neoadjuvant and adjuvant therapy versus adjuvant therapy in high-risk upper tract urothelial carcinoma: a propensity matched multicenter analysis (ROBUUST 2.0 International Collaborative Group)Ahmed Eraky, Reuben Ben-David, Gabriele Bignante, et al.
Urologic Oncology|March 3, 2026
Perioperative and oncologic outcomes of extirpative surgery for upper tract urothelial cancer in octogenariansTaibo Li, Stephan Brönimann, Ahmed Eraky, et al.
World Journal of Urology|January 11, 2026
Real-world outcomes of bladder-sparing strategies for BCG-unresponsive non-muscle-invasive bladder cancer: a multicenter studyPietro Scilipoti, Paolo Zaurito, Mattia Longoni, et al.
Urology Practice|June 22, 2026
Metachronous contralateral recurrence in upper tract urothelial carcinoma: a multi-institutional competing-risks analysis from the ROBUUST 3.0 registryFrancesco Ditonno, Alessandro Veccia, Giacomo Musso, et al.
World Journal of Urology|September 2, 2025
Radical nephroureterectomy vs kidney sparing surgery for upper tract urothelial carcinoma in solitary kidney patients: a multi-institutional analysis of the ROBUUST 2.0 registryFrancesco Ditonno, Alessandro Veccia, Gabriele Bignante, et al.
Pageof 38